Publisher
Springer Science and Business Media LLC
Reference38 articles.
1. Pucci, C., Martinelli, C., & Ciofani, G. (2019). Innovative approaches for cancer treatment: Current perspectives and new challenges. Ecancermedicalscience, 13, 961–987.
2. Tan, S., Li, D., & Zhu, X. (2020). Cancer immunotherapy: Pros, cons and beyond. Biomedicine & Pharmacotherapy, 124, 109821–109832.
3. Shiravand, Y., Khodadadi, F., Kashani, S. M. A., Hosseini-Fard, S. R., Hosseini, S., Sadeghirad, H., Ladwa, R., O’Byrne, K., & Kulasinghe, A. (2022). Immune checkpoint inhibitors in cancer therapy. Current Oncology, 29, 3044–3060.
4. Topalian, S. L., Drake, C. G., & Pardoll, D. M. (2015). Immune checkpoint blockade: A common denominator approach to cancer therapy. Cancer Cell, 27, 450–461.
5. Han, Y., Liu, D., & Li, L. (2020). PD-1/PD-L1 pathway: Current researches in cancer. American Journal of Cancer Research, 10, 727–742.